GlaxoSmithKline Says Roche's Herceptin Infringes Patents

Published: Sep 23, 2010

WILMINGTON, Del., Sept 21 (Reuters) - Drugmaker GlaxoSmithKline sued Swiss rival Roche Holding AG (ROG.VX) on Tuesday for infringing a patent when it produces its cancer drug Herceptin, according to court documents filed on Monday.

Back to news